InflaRx Files For Mixed Shelf Of Up To $250M
Portfolio Pulse from Benzinga Newsdesk
InflaRx has filed for a mixed shelf offering of up to $250 million. The company plans to use the proceeds for general corporate purposes, including research and development.
June 30, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
InflaRx's filing for a mixed shelf offering of up to $250 million could potentially dilute existing shareholders' equity. However, the funds raised will be used for general corporate purposes, including research and development, which could lead to long-term growth.
The mixed shelf offering could dilute existing shareholders' equity, which may negatively impact the stock price in the short term. However, the funds raised will be used for research and development, which could lead to new products or improvements in existing ones, potentially driving long-term growth and a positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100